Mabwell receives IND Approval from FDA for Novel B7-H3 ADC 7MW3711

Daiichi Sankyo plans €1B expansion to enhance Antibody-Drug Conjugate production in Germany

Gilead signs antibody agreement with Biocytogen amid growing ADC excitement

Datopotamab deruxtecan’s BLA accepted in the US for advanced NSCLC in previously treated patients